wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q33856901-C1C75E9E-1764-4242-ABE3-6E0A7A04CDA7
Q33856901-C1C75E9E-1764-4242-ABE3-6E0A7A04CDA7
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33856901-C1C75E9E-1764-4242-ABE3-6E0A7A04CDA7
Evaluation of soluble CD200 levels in type 2 diabetic foot and nephropathic patients: association with disease activity
P2860
Q33856901-C1C75E9E-1764-4242-ABE3-6E0A7A04CDA7
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33856901-C1C75E9E-1764-4242-ABE3-6E0A7A04CDA7
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
d7cb926bbe34f5788189c0f4215f4f225af170dc
P2860
Effects of omalizumab on eosinophil cationic peptide, 25-hydroxyvitamin-D, IL-1β and sCD200 in cases of Samter's syndrome: 36 months follow-up.